Articles de recherche

Découvrez nos prochaines rencontres scientifiques et activités éducatives axées sur la promotion de la collaboration, le partage de nouvelles données probantes et le renforcement des meilleures pratiques dans le traitement des patients atteints de troubles cardiovasculaires liés au cancer.

Cancer Treatment–Related Cardiotoxicity: Current State of Knowledge and Future Research Priorities

Auteurs :

Nonniekaye Shelburne, Bishow Adhikari, Joanna Brell, Myrtle Davis, Patrice Desvigne-Nickens, Andrew Freedman, Lori Minasian, Thomas Force, Scot C. Remick

Publication :

Journal of the National Institute of Cancer

Date :

September 10, 2014

Lien vers l'article

Breast Cancer Chemotherapy and Your Heart

Auteurs :

Christine Unitt, Kamaneh Montazeri, Sara Tolaney, Javid Moslehi

Publication :

Circulation

Date :

2014

Lien vers l'article

Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer.

Auteurs :

Hurvitz SA, Bosserman LD, Chan D, Hagenstad CT, Kass FC, Smith FP, Rodriguez GI, Childs BH, Slamon DJ.

Publication :

Spingerplus

Date :

2014 May 12

Lien vers l'article

Anthracycline-related cardiotoxicity in childhood cancer survivors.

Auteurs :

Lipshultz SE, Karnik R, Sambatakos P, Franco VI, Ross SW, Miller TL.

Publication :

Current Opinion in Cardiology

Date :

2014 Jan

Lien vers l'article

Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy

Auteurs :

Sean A. Virani, MD, MSc, MPH, FRCPC (Co-Chair, Primary Panel)∗,correspondencePress enter key for correspondence informationemailPress enter key to Email the author, Susan Dent, MD, FRCPC (Co-Chair, Primary Panel)∗, Christine Brezden-Masley, MD, PhD, FRCPC (Primary Panel), Brian Clarke, MD, FRCPC, FACC (Primary Panel), Margot K. Davis, MD, FRCPC (Primary Panel), Davinder S. Jassal, MD, FACC, FRCPC (Primary Panel), Christopher Johnson, MD, FRCPC (Primary Panel), Julie Lemieux, MD, MSc, FRCPC (Primary Panel), Ian Paterson, MD, FRCPC (Primary Panel), Igal A. Sebag, MD, FRCPC, FACC, FASE (Primary Panel), Christine Simmons, MD, MSc, FRCPC (Primary Panel), Jeffrey Sulpher, MD, FRCPC (Primary Panel), Kishore Thain, MD, FRCPC (Primary Panel), Paaldinesh Thavendiranathan, MD, MSc, FRCPC (Primary Panel), Jason R. Wentzell, BScPharm, ACPR (Primary Panel), Nola Wurtele, MN, NP(A) (Primary Panel), Marc André Côté, MD, FRCPC (Secondary Panel), Nowell M. Fine, MD, MS, FRCPC (Secondary Panel), Haissam Haddad, MD, FRCPC, FACC (Secondary Panel), Bradley D. Hayley, MD, FRCPC (Secondary Panel), Sean Hopkins, BSc (Hon), BSP (Secondary Panel), Anil A. Joy, MD (Secondary Panel), Daniel Rayson, MD, FRCPC, FACP (Secondary Panel), Ellamae Stadnick, MD, MSc, FRCPC (Secondary Panel), Lynn Straatman, MD, FRCPC (Secondary Panel)

Publication :

Canadian Journal of Cardiology

Date :

July 2016

Lien vers l'article

Cancer-drug discovery and cardiovascular surveillance.

Auteurs :

Groarke JD, Cheng S, Moslehi J.

Publication :

New England Journal of Medicine

Date :

2013 Nov 7

Lien vers l'article

BNP predicts chemotherapy-related cardiotoxicity and death: comparison with gated equilibrium radionuclide ventriculography.

Auteurs :

Skovgaard D, Hasbak P, Kjaer A.

Publication :

PLoS One

Date :

2014 May 6

Lien vers l'article

ABCDE Steps to Prevent Heart Disease in Breast Cancer Survivors

Auteurs :

Kamaneh Montazeri, Christine Unitt, JoAnne M. Foody, Jay R. Harris, Ann H. Partridge and Javid Moslehi

Publication :

Circulation

Date :

2014

Lien vers l'article

A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor.

Auteurs :

Lubieniecka JM, Graham J, Heffner D, Mottus R, Reid R, Hogge D, Grigliatti TA, Riggs WK.

Publication :

Frontiers in Genetics

Date :

2013 Nov 11

Lien vers l'article

Amelioration of doxorubicin induced cardio-and hepato-toxicity by carotenoids.

Auteurs :

Indu R, Azhar TS, Nair A, Nair CK.

Publication :

Journal of Cancer Research and Therapeutics

Date :

2014 Jan-Mar

Lien vers l'article